Kaitlin J. Stanley

Kaitlin J. Stanley

Auto-generated profile, based on publicly available information

Kaitlin J. Stanley

Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in European Journal of Human Genetics
Verified
Journal Article
Open access
PDF file
KSKaitlin J. Stanley
Kaitlin J. Stanley
KKKelsey J. Kalbfleisch
Kelsey J. Kalbfleisch
OMOlivia M. Moran
Olivia M. Moran
RCRajiv R. Chaturvedi
Rajiv R. Chaturvedi
MRMaian Roifman
Maian Roifman
RJRebekah K. Jobling
Rebekah K. Jobling
Pathogenic variants in NOTCH1 are associated with non-syndromic congenital heart disease (CHD) and Adams–Oliver syndrome (AOS). The clinical presentation of individuals with damaging NOTCH1 variants is characterized by variable expressivity and incomplete penetrance; however, data on systematic phenotypic characterization are limited. We report the genotype and phenotype of a cohort of 33 individuals (20 females, 13 males; median age 23.4 years, range 2.5–68.3 years) from 11 families with causative NOTCH1 variants (9 inherited, 2 de novo; 9 novel), ascertained from a proband with CHD. We describe the cardiac and extracardiac anomalies identified in these 33 individuals, only four of whom met criteria for AOS. The most common CHD identified was tetralogy of Fallot, though various left- and right-sided lesions and septal defects were also present. Extracardiac anomalies identified include cutis aplasia (5/33), cutaneous vascular anomalies (7/33), vascular anomalies of the central nervous system (2/10), Poland anomaly (1/33), pulmonary hypertension (2/33), and structural brain anomalies (3/14). Identification of these findings in a cardiac proband cohort supports NOTCH1-associated CHD and NOTCH1-associated AOS lying on a phenotypic continuum. Our findings also support (1) Broad indications for NOTCH1 molecular testing (any familial CHD, simplex tetralogy of Fallot or hypoplastic left heart); (2) Cascade testing in all at-risk relatives; and (3) A thorough physical exam, in addition to cardiac, brain (structural and vascular), abdominal, and ophthalmologic imaging, in all gene-positive individuals. This information is important for guiding the medical management of these individuals, particularly given the high prevalence of NOTCH1 variants in the CHD population.

2 March 2026 in Journal of Genetic Counseling
Verified
Journal Article
Open access
KSKaitlin J. Stanley
Kaitlin J. Stanley
IMIan M. MacFarlane
Ian M. MacFarlane
SASusan Randall Armel
Susan Randall Armel
DCDavid Chitayat
David Chitayat
BJBrittney Johnstone
Brittney Johnstone
Burnout arises from prolonged work‐related stress, leading to a chronic state of exhaustion, cynicism, and diminished professional efficacy. Previous studies have shown that ~50% of genetic counselors (GCs) experience burnout. This has negative implications for the GCs themselves, their employers, and patient care. Research in other healthcare professions has found a negative correlation between burnout and job satisfaction and a positive correlation between burnout and turnover intention. To investigate aspects of job satisfaction associated with burnout and aspects of burnout associated with turnover intention, a cross‐sectional survey was administered via the listservs of three genetic counseling professional organizations. The survey included demographic questions, validated measures of burnout (the Maslach Burnout Inventory – General Survey) and job satisfaction (the Job Satisfaction Survey and select scales from the Job Satisfaction Questionnaire), a binary question assessing turnover intention, and two optional open‐ended questions eliciting opinions on ways to improve job satisfaction. Of 228 respondents, 70 (30.7%) indicated that they were considering leaving their current job due to burnout. Logistic multiple regression analysis ( n = 224) including subscales of burnout revealed that Exhaustion ( p = 0.0004) and Cynicism ( p < 0.0001) significantly predicted turnover intention. Linear multiple regression analyses ( n = 206–207) including subscales of job satisfaction revealed that satisfaction with Nature of Work was a significant predictor of Exhaustion, Cynicism, and reduced Professional Efficacy ( p < 0.0001). Significant predictors of Exhaustion included satisfaction with Operating Conditions ( p = 0.02), Working Hours ( p = 0.02), and Working Conditions ( p = 0.01), while satisfaction with Empowerment and Participation ( p = 0.03) was a significant predictor of Cynicism. Responses to the open‐ended questions (147/228, 64.5%) revealed additional areas of job dissatisfaction. We propose several strategies to improve job satisfaction and ameliorate GC burnout at the organizational level. These strategies may increase the effectiveness of GCs in their jobs, improve patient care, promote professional longevity, and ultimately save organizations money by reducing turnover.

1 April 2026
Verified
Journal Article
Open access
KSKaitlin J Stanley
Kaitlin J Stanley
IMIan M MacFarlane
Ian M MacFarlane
SASusan Randall Armel
Susan Randall Armel
DCDavid Chitayat
David Chitayat
BJBrittney Johnstone
Brittney Johnstone
Burnout arises from prolonged work-related stress, leading to a chronic state of exhaustion, cynicism, and diminished professional efficacy. Previous studies have shown that ~50% of genetic counselors (GCs) experience burnout. This has negative implications for the GCs themselves, their employers, and patient care. Research in other healthcare professions has found a negative correlation between burnout and job satisfaction and a positive correlation between burnout and turnover intention. To investigate aspects of job satisfaction associated with burnout and aspects of burnout associated with turnover intention, a cross-sectional survey was administered via the listservs of three genetic counseling professional organizations. The survey included demographic questions, validated measures of burnout (the Maslach Burnout Inventory - General Survey) and job satisfaction (the Job Satisfaction Survey and select scales from the Job Satisfaction Questionnaire), a binary question assessing turnover intention, and two optional open-ended questions eliciting opinions on ways to improve job satisfaction. Of 228 respondents, 70 (30.7%) indicated that they were considering leaving their current job due to burnout. Logistic multiple regression analysis (n = 224) including subscales of burnout revealed that Exhaustion (p = 0.0004) and Cynicism (p < 0.0001) significantly predicted turnover intention. Linear multiple regression analyses (n = 206-207) including subscales of job satisfaction revealed that satisfaction with Nature of Work was a significant predictor of Exhaustion, Cynicism, and reduced Professional Efficacy (p < 0.0001). Significant predictors of Exhaustion included satisfaction with Operating Conditions (p = 0.02), Working Hours (p = 0.02), and Working Conditions (p = 0.01), while satisfaction with Empowerment and Participation (p = 0.03) was a significant predictor of Cynicism. Responses to the open-ended questions (147/228, 64.5%) revealed additional areas of job dissatisfaction. We propose several strategies to improve job satisfaction and ameliorate GC burnout at the organizational level. These strategies may increase the effectiveness of GCs in their jobs, improve patient care, promote professional longevity, and ultimately save organizations money by reducing turnover.

10 August 2025 in BMJ Open
Verified
Journal Article
Open access
KSKaitlin J Stanley
Kaitlin J Stanley
CCCaitlin Chisholm
Caitlin Chisholm
MGMeredith K Gillespie
Meredith K Gillespie
OCOana Caluseriu
Oana Caluseriu
NSNatalie del Signore
Natalie del Signore
GCGregory Costain
Gregory Costain
Introduction: Rare diseases (RD) are collectively common and often genetic. Families value and can benefit from precise molecular diagnoses. Prolonged diagnostic odysseys exacerbate the burden of RD on patients, families and the healthcare system. Genome sequencing (GS) is a near-comprehensive test for genetic RD, but existing care models—where consultation with a medical geneticist is a prerequisite for testing—predate GS and may limit access or delay diagnosis. Evidence is needed to guide the optimal positioning of GS in care pathways. While initiating GS prior to geneticist consultation has been trialled in acute care settings, there are no data to inform the utility of this approach in outpatient care, where most patients with RD seek genetics services. We aim to evaluate the diagnostic yield, time to diagnosis, clinical and personal utility and incremental cost-effectiveness of GS initiated at the time of referral triage (pre-geneticist evaluation) compared with standard of care. Methods and analysis: 200 paediatric patients referred to one of two large genetics centres in Ontario, Canada, for suspected genetic RD will be randomised into a 1:1 ratio to the intervention (GS first) or standard of care (geneticist first) arm. An unblinded, permuted block randomisation design will be used, stratified within each recruitment site by phenotype and prior genetic testing. The primary outcome measure is time to genetic diagnosis or to cessation of active follow-up. Survival analysis will be used to analyse time-to-event data. Additional measures will include patient-reported and family-reported measures of satisfaction, understanding and perceived test utility, clinician-reported measures of perceived test utility and management impact, and healthcare system utilisation and costs. Ethics and dissemination: This study was approved by Clinical Trials Ontario. Results will be disseminated, at minimum, via peer-reviewed journals, professional conferences and internal reports to funding bodies. Efforts will be made to share aggregated study results with participants and their families. Trial registration number: NCT06935019 .